Adagene (ADAG) Assets (2019 - 2026)
Adagene (ADAG) posted quarterly Assets of $78.3 million for Q4 2025, down 12.33% year-over-year from $89.3 million in Q4 2024, and up 17.66% quarter-over-quarter from $66.5 million in Q2 2025.
Adagene (ADAG) Assets (2019 - 2026) Analysis & Trends
Adagene (ADAG) has reported Assets for 7 consecutive years, with $78.3 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Assets fell 12.33% year-over-year to $78.3 million; the TTM figure through Dec 2025 stood at $78.3 million (down 12.33% YoY), while the FY2025 annual figure was $78.3 million, down 12.33% from the prior year.
- Assets climbed to $78.3 million in Q4 2025 per ADAG's latest filing, from $66.5 million in the prior quarter.
- Across five years, Assets topped out at $217.9 million in Q2 2021 and bottomed at $135.3 in Q2 2023.
- Historically, Assets has averaged $101.0 million across 5 years, with a median of $95.0 million in 2024.
- Annual changes were most pronounced in 2022 — Assets plunged 100.0% — and 2024, when it jumped 74484683.94%.
- Adagene's Assets stood at $189.5 million in 2021, then declined by 19.58% to $152.4 million in 2022, then retreated by 24.06% to $115.7 million in 2023, then retreated by 22.86% to $89.3 million in 2024, then slipped by 12.33% to $78.3 million in 2025.
- Business Quant data shows ADAG's Assets at $78.3 million in Q4 2025, $66.5 million in Q2 2025, and $89.3 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Adagene | 310.54 Mn | 310.54 Mn | - | 133.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 133.58 Mn |
| Dec 31, 2025 | 78.26 Mn |
| Jun 30, 2025 | 66.52 Mn |
| Dec 31, 2024 | 89.27 Mn |
| Jun 30, 2024 | 100.78 Mn |
| Dec 31, 2023 | 115.73 Mn |
| Jun 30, 2023 | 135.30 |
| Dec 31, 2022 | 152.40 Mn |
| Jun 30, 2022 | 178.56 |
| Dec 31, 2021 | 189.51 Mn |
| Jun 30, 2021 | 217.86 Mn |
| Dec 31, 2020 | 84.26 Mn |
| Dec 31, 2019 | 105.89 Mn |